Clinical Trials on Diabetes Mellitus, Noninsulin Dependent in Mexico
Total 711 results
-
Eli Lilly and CompanyCompletedType 2 Diabetes MellitusUnited States, Puerto Rico, Mexico
-
Instituto Mexicano del Seguro SocialCompleted
-
University of New MexicoWithdrawn
-
TakedaCompletedType 2 Diabetes MellitusUnited States, Poland, Ukraine, United Kingdom, Mexico, Spain, Romania, Israel, Canada, New Zealand, Singapore, Russian Federation, Chile, Puerto Rico, Thailand, Hungary, Austria, Lithuania, Malaysia, Philippines, Australia, India, South... and more
-
Hoffmann-La RocheCompletedDiabetes Mellitus Type 2United States, France, Canada, Mexico, Guatemala, Germany, Brazil, Puerto Rico, Costa Rica
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Canada, France, Guatemala, Italy, Korea, Republic of, Mexico, Poland, Russian Federation
-
University of GuadalajaraCompletedPreDiabetes | PrehypertensionMexico
-
PfizerCompletedDiabetes Mellitus, Type 2United States, Taiwan, Slovakia, Mexico, Canada, Hungary
-
AstraZenecaBristol-Myers SquibbCompletedType 2 DiabetesUnited States, Peru, Mexico, Colombia, Costa Rica
-
Bristol-Myers SquibbMerck Sharp & Dohme LLCCompletedType 2 Diabetes MellitusUnited States, Argentina, Canada, Mexico, Peru, Taiwan, Australia, Philippines, Thailand, Brazil, Chile, India, Russian Federation, Ukraine
-
SanofiCompletedType 2 Diabetes MellitusUnited States, Chile, Czech Republic, Denmark, France, Germany, Hungary, Lithuania, Mexico, Poland, Romania, Slovakia, Sweden
-
SanofiTerminatedDiabetes Mellitus, Type 2United States, Romania, Russian Federation, Spain, Sweden, India, Mexico, Denmark, Finland, Hungary, Italy, Korea, Republic of, Chile, Puerto Rico
-
Eli Lilly and CompanyRecruitingDiabetes Mellitus, Type 2United States, Canada, Mexico, Argentina, Puerto Rico
-
SanofiCompletedType 2 Diabetes MellitusGermany, Spain, United States, Canada, Czechia, Hungary, Mexico, Russian Federation
-
Lexicon PharmaceuticalsSanofiCompletedType 2 Diabetes MellitusUnited States, Bulgaria, Canada, Czechia, France, Italy, Latvia, Mexico, Russian Federation, Slovakia, Spain, United Kingdom
-
GlaxoSmithKlineCompletedDiabetes Mellitus, Type 2United States, Argentina, Canada, Mexico, Spain, Estonia, Pakistan, Philippines
-
Avanir PharmaceuticalsCompletedPain | Diabetic NeuropathyUnited States
-
Eli Lilly and CompanyActive, not recruitingType 2 Diabetes | T2DUnited States, Mexico, Argentina, Puerto Rico
-
AstraZenecaEli Lilly and CompanyCompletedType 2 Diabetes MellitusUnited States, Brazil, Italy, Korea, Republic of, Mexico, Poland, Russian Federation, Spain, Turkey, United Kingdom, South Africa, Argentina, Canada, Germany, Hungary, Israel, Romania, Slovakia, India, Belgium, France, Puerto Rico
-
Eli Lilly and CompanyCompletedType 2 Diabetes MellitusRussian Federation, United States, Puerto Rico, Australia, Taiwan, Israel, Spain, Canada, Greece, Argentina, Poland, Romania, Mexico, Slovakia, Brazil
-
Daiichi Sankyo, Inc.CompletedType 2 DiabetesUnited States, Peru, Mexico
-
Andromeda Biotech Ltd.CompletedType 1 Diabetes MellitusUnited States, Russian Federation, Israel, Spain, Lithuania, Germany, Austria, Belarus, Canada, Czech Republic, Finland, Hungary, Italy, Poland
-
AstraZenecaEli Lilly and CompanyCompletedType 2 Diabetes MellitusAustralia, France, Italy, Korea, Republic of, Mexico, Spain, Poland, Romania, South Africa, Argentina, Austria, Belgium, Germany, Hungary, Israel, Slovakia, Greece, India, Taiwan, Canada, Czech Republic
-
Regeneron PharmaceuticalsCompletedNonproliferative Diabetic RetinopathyUnited States, Germany, Hungary, Japan, Puerto Rico, United Kingdom
-
AstraZenecaCompletedDiabetes Mellitus, Type 2United States, Thailand, United Kingdom, Malaysia, New Zealand, Taiwan, Turkey, Canada, Mexico, Israel, India, Argentina, Brazil, Russian Federation, Australia, Korea, Republic of, Italy, Philippines, Colombia, Poland, Chile, Finland and more
-
SanofiCompletedType 2 Diabetes MellitusUnited States, Finland, South Africa, Canada, Mexico, Chile, Spain, Russian Federation, France, Germany, Hungary, Portugal, Romania
-
AstraZenecaCompletedType 2 DiabetesUnited States, Mexico, Puerto Rico, Israel, Sweden, Italy, Philippines, Argentina
-
PfizerCompletedDiabetes, Type 2Canada, United States, Korea, Republic of, Taiwan, Mexico, Hungary, Slovakia
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, United Kingdom, Mexico, Russian Federation, Japan, Canada, Italy, South Africa, Romania
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Puerto Rico, United States, Romania, United Kingdom, Spain, Mexico, Austria, South Africa, Germany, Ukraine, India
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Puerto Rico, Malaysia, Mexico, Turkey, Thailand, Korea, Republic of
-
AstraZenecaCompletedType II Diabetes MellitusSweden, Mexico, Peru, United Kingdom, Germany, Hungary, Latvia, Lithuania, Poland, Chile, Romania
-
SanofiCompletedType 1 Diabetes MellitusFrance, Czechia, Chile, Israel, Spain, Hungary, Mexico, Serbia, Japan, Canada, Brazil, Sweden, Denmark, Argentina, United States, Bulgaria, Germany, Italy, Latvia, North Macedonia, Poland, Romania, Russian Federation, United Kingdom
-
PfizerCompletedDiabetic NephropathiesUnited States, Korea, Republic of, Sweden, Canada, Hong Kong, Serbia, Denmark, Australia, Malaysia, Slovakia, South Africa, India, United Kingdom, Poland, Mexico
-
Eli Lilly and CompanyCompletedType 2 Diabetes MellitusUnited States, Hungary, Puerto Rico, Spain, Australia, Korea, Republic of, Mexico, Japan, Germany, Russian Federation, Taiwan, Slovakia, Argentina, Czechia, India, Italy
-
Janssen Research & Development, LLCCompletedDiabetes Mellitus, Type 2United States, India, China, Brazil, Greece, Malaysia, Mexico, Philippines, Poland, Russian Federation
-
GlaxoSmithKlineCompletedDiabetes Mellitus, Type 2United States
-
AstraZenecaCompleted
-
Goldfinch Bio, Inc.TerminatedDiabetic Nephropathies | Glomerulosclerosis, Focal Segmental | Minimal Change DiseaseUnited States
-
Eli Lilly and CompanyActive, not recruitingGlucose Metabolism Disorders | Diabetes Mellitus, Type 2 | Diabetes Mellitus | Endocrine System Diseases | Type2 Diabetes | Metabolic Disease | T2DM (Type 2 Diabetes Mellitus) | T2DUnited States, India, Australia, United Kingdom, Mexico, Brazil, Israel, France, Italy
-
Hoffmann-La RocheCompletedDiabetes Mellitus Type 2United States, France, Switzerland, Germany, South Africa, Korea, Republic of, Puerto Rico, Canada, Taiwan, Spain, Poland, Slovakia, Thailand, Mexico, Turkey, Australia, Greece, Norway, Sweden, Peru, Romania, Argentina, United Kingdom
-
TakedaTerminatedType 2 Diabetes MellitusUnited States, Poland, Ukraine, Taiwan, Bulgaria, Romania, Slovakia
-
AstraZenecaTerminatedType 2 Diabetes MellitusUnited States
-
Novartis PharmaceuticalsCompletedDiabetes Mellitus, Type 2Austria, Argentina, Australia, Belgium, Brazil, Canada, Chile, China, Colombia, Denmark, Ecuador, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Italy, Malaysia, Mexico, Netherlands, Norway, Peru, Poland, Russian Federation and more
-
Chromaderm, Inc.CompletedDiabetic RetinopathyUnited States, Canada, France, Denmark, Australia, Netherlands, Taiwan, Spain, Italy, Germany, Portugal, United Kingdom, Russian Federation, Poland, India, Brazil, Mexico
-
SanofiCompletedDiabetes Mellitus, Type 2United States, Brazil, Netherlands, Portugal, Spain, Turkey, India, Austria, Egypt, Greece, Israel, Mexico, United Kingdom, Korea, Republic of, Hong Kong, Colombia, Lebanon
-
OcuTerra Therapeutics, Inc.ParexelCompleted
-
Merck Sharp & Dohme LLCPfizerActive, not recruitingType 2 Diabetes MellitusUnited States, Belgium, Canada, Colombia, Costa Rica, Dominican Republic, France, Guatemala, Hungary, Israel, Italy, Malaysia, Mauritius, Mexico, Philippines, Poland, Russian Federation, Saudi Arabia, Turkey, Ukraine, United Arab... and more
-
University of GuadalajaraActive, not recruitingHyperglycemia | PreDiabetes | Impaired Glucose Tolerance | Resistance, InsulinMexico
-
University of GuadalajaraCompletedImpaired Glucose Tolerance | Prediabetes | Impaired Fasting GlucoseMexico